newsfilter
← Latest News
Business Wire·

Sierra Oncology Reports First Quarter 2022 Results

Sierra Oncology, Inc. (NASDAQ:SRRA), a late-stage biopharmaceutical company with a mission to deliver targeted therapies that treat rare forms of cancer, today reported its financial and operating results for the first quarter ended March 31, 2022. "